关键数据
1.810今开
1.810最高
21.31K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.03%换手率
1.780昨收
1.700最低
29.02K成交额
亏损市盈率静
3.70市净率
0.00%股息率 TTM
-31.56%ROA
4.19152周最高
0.28量比
-251.39M净利润
76.28M总股本
-1.7653每股收益TTM
1.65Beta
-191.81%ROE
1.09052周最低
6.18%振幅
100.00%毛利率
131.20M总市值
4.70回报/风险
6.36%风险率
操作建议
Cibus Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名106/200位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价14.67。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Cibus Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Edwards Lifesciences Corp
EW
33
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Cibus Inc简介
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
公司代码CBUS
公司Cibus Inc
CEOBeetham (Peter Ronald)
网址https://www.cibus.com/
公司股东
常见问题
Cibus Inc(CBUS)的当前股价是多少?
Cibus Inc(CBUS)的当前股价是 1.79。
现在Cibus Inc(CBUS)的股票是买入、持有还是卖出?
根据分析师评级,Cibus Inc(CBUS)的总体评级为买入,目标价格为14.67。
Cibus Inc(CBUS)股票的每股收益(EPS TTM)是多少
Cibus Inc(CBUS)股票的每股收益(EPS TTM)是-2.78。